Henry Ford Health 10th Annual Multidisciplinary Head and Neck Cancer Symposium

The ECP pivotal is in full swing. Albuquerque, Tucson, Missoula, Buffalo, Norfolk, and NYC officially on board. Great cases by the 🐅 and our graduating fellows Fola and Phil! Awesome colleagues visited and helped us through the cases. Theodore Schreiber tlalondemd on the assist

Today, #FDA approved the first #genetherapy to treat adults with severe Hemophilia A, #Roctavian. Approximately 1 in 10,000 people have the blood clotting disorder. Read the statement from ASGCT President Jeffrey Chamberlain, PhD (University of Washington): asgct.org/publications/n…

Navigating Personalized Cancer Care by Mapping the Tumor. Learn how distinct tumor biomarkers within each tumor type can help inform your clinical decision-making and the treatment journey for your patients. bit.ly/4010x7F

Pirtobrutinib: a new hope for patients with BTK inhibitor–refractory lymphoproliferative disorders loom.ly/Qq7n4m4

Congratulations to Dr. Kenneth Ataga for being nominated for the 2023 Health Care Heroes Award by the Memphis Business Journal!

According to data from the final OS analysis of the ExteNET trial, neratinib did not significantly improve overall survival vs placebo for patients with early-stage HER2+ breast cancer in the extended adjuvant setting. #bcsm ow.ly/7I2P50PFYOA

"We don't live for money and titles...I think we live for love. We live for joy. We live for passion." Dominika Kulczyk, founder and president at Kulczyk Foundation, spoke to Forbes CEO Mike Federle about what drives her to make a difference at the #ForbesPhilanthropy Summit.

In Science, researchers engineered #Cancer cells with and without specific chromosome abnormalities, showing how tumors rely on them for survival and clarifying the biological role of aneuploidy. Check out the study on #WorldCancerResearchDay: scim.ag/4cZ

Patient first; person first - The Lancet Oncology thelancet.com/journals/lanon…

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions | NEJM nejm.org/doi/full/10.10…

Check out Cancer Center Director Dr. D. Neil Hayes, Program Director Dr. David Schwartz, and former UTHSC Trainee Dr. Oluchukwu Oluoha for their commentary published in the Journal of Clinical Oncology on personalized care in head and neck cancer. ascopubs.org/doi/full/10.12…

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee ow.ly/XAtR50S48bg #myeloidneoplasia #transplantation

#ESMO24 Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2 🔍One dose of ipilimumab and two doses of nivolumab prior to surgery, 64% had cT4 tumors. 3-year DFS➡️💯% Presented by Myriam Chalabi

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

Zolbetuximab Plus Chemotherapy Wins EU Approval for Advanced CLDN18.2+ Gastric/GEJ Cancer onclive.com/view/zolbetuxi…

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. #MultipleMyeloma Read more here: hubs.li/Q03S55xq0

Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer (SUPREMO phase 3 trial) nej.md/3Jxd3sI Editorial: Omission of Chest-Wall Irradiation after Mastectomy for Breast Cancer nej.md/49BPQQt #Oncology